Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2009 Jan 21;1791(4):314–320. doi: 10.1016/j.bbalip.2009.01.004

Fig. 4.

Fig. 4

MLCL is an acyl acceptor but not an acyl donor of tafazzin. A, Purified tafazzin (MBP-TAZ, 2.5 μg) was incubated for 5 min with 10 μM 1-palmitoyl-2[14C]linoleoyl-PC (0.1 μCi) and 50 μM of DLCL or MLCL, followed by quantification of the transacylation products ([14C]MLCL or [14C]CL). B, MBP-TAZ (2.5 μg) was incubated for 5 min with 5 μM[14C]LPC (0.05 μCi) and 50 μM of MLCL or CL, followed by quantification of [14C]PC. Results are expressed as mean ± SEM of triplicate determinations.